PathoQuest’s leadership team brings an extensive experience in the Pharmaceutical and CRO/CDMO industry with successful leading roles in international companies.
Since April 16, 2026, PathoQuest has joined Charles River Laboratories, further expanding our capabilities and commitment to advancing biosafety testing and quality control for the biopharmaceutical industry.
Management team
READ MORE
Jean-François Brepson has over 20 years of leadership experience in the Pharmaceutical Industry. Prior to joining PathoQuest, Mr. Brepson was a Senior Vice-President at IPSEN where he was responsible for leading the global GI-Oncology & Endocrinology Franchise.
Mr. Brepson has an Engineering Degree in Data Management System and a Master’s degree in Foreign Trade. He has also earned “The Leadership & Innovation Certificate” for HEC in Paris and “The Blue Ocean Strategy Certificate” from INSEAD in Fontainebleau-France.
READ MORE
Dr. Côté has nearly 20 years of experience in industry with a focus on applying & expanding the use of NGS in the biosafety testing field. She recently was Head of NGS R&D Testing Services at MilliporeSigma, a well-known stakeholder of the biosafety testing and viral vector manufacturing industry. She started her career as a Senior Scientist at Intronn Inc, and then moved to Innovative Biosensors Inc where she developed and engineered biosensors for rapid biodefense and clinical pathogen detection. Colette received her Ph.D. in Molecular Biology, Cell Biology, and Biochemistry from the Brown University and completed her postdoctoral fellowship in the Genetics and Biochemistry Branch at the NIH. She contributed to various papers, publications, and patents throughout her career.
READ MORE
Prior to joining us, Mr. Cazergue was Finance & Operations Director at Corin France with responsibilities for coordinating the support functions in a post-acquisition and business recovery environment. Before, he was VP of Finance for EMEA APAC at Resmed, a medical device company. Previous to the above, he was CFO at Sanofi Aventis Turkey where he supported the company’s strong business growth and organizational development. He also was also a key contributor to the local merger process of Rhone Poulenc/HMR and between Sanofi/Aventis. Eric Cazergue holds a Master of Business Administration (MBA) from Emlyon Business School (EM Lyon) in Lyon, France, and a Master’s in Finance and Accounting from the University of Lyon.
READ MORE
Dr. Sébastien Renouf has 20 years of experience in Regulatory Affairs, Quality Assurance, and Safety Control for Cell & Gene Therapy. Before joining PathoQuest, Dr. Renouf was Chief Pharmaceutical Officer at CELLforCURE a CDMO specialized in the CART Cells manufacturing and part of the Novartis Group, where he supported the implementation of inspection and marketing authorization accreditation processes. Dr. Renouf has a Pharmacy degree from Paris XI University and is a Therapeutic Biotechnology graduate from Paris VII University and an internship of the Ile-de-France region with an Industrial and Biomedical Pharmacy specialty.
READ MORE
Dr. Guillaume Deplaine has 10 years of experience in the Biotechnology industry. Prior to joining PathoQuest, Dr. Deplaine was the Quality Control and Analytical Development Head at CELLforCURE a CDMO specialized in CART Cells manufacturing, and was part of the Novartis Group. Before, he was Quality Control Head at THERAVECTYS, a company based on lentiviral technology to develop vaccines. Previous to the above, he was Project manager for medical devices in the genetic diagnosis field. Dr. Deplaine is graduated from the University of Pierre et Marie CURIE/Pasteur Institute and holds a Ph.D in Molecular & Cell Biology. He is co-author of several publications and patents.
READ MORE
Michal Dysko brings more than 20 years of leadership experience in clinical research and biopharma services, with a proven track record in driving commercial growth and forging strategic partnerships. Before joining PathoQuest, he led business development and commercial teams at Medicover Integrated Clinical Services and Synevo Central Labs, and advised biopharma and CRO organizations in Europe and North America on scaling their operations. Michal holds an MBA from the University of Quebec at Montreal and the Warsaw School of Economics.
READ MORE
Florence Suavet holds a PhD in Virology and has over 20 years of experience in the biopharmaceutical industry, with a strong focus on analytical method development, validation, and transfer. Her career has spanned public research institutions, regulatory agencies, and pharmaceutical companies of various sizes. Florence is recognized for her deep knowledge of viral safety, CMC strategy, and Life Cycle Management. Her thorough understanding of biomanufacturing processes and long-standing involvement in quality systems make her a trusted reference in the field of Biosafety Quality Control.
THE FOUNDER
Marc Eloit, Prof.
Founder and Scientific Advisor
Marc Eloit served as a Professor of Virology at the Veterinary School of Maisons-Alfort and held the position of Head of the Pathogen Discovery laboratory at Institut Pasteur Paris until October 2023.
He is a pioneer and consultant in virus discovery and safety of biologicals. He has published a large number of scientific papers in the field of virology.
He was member of the Virus Safety of Medicinal Products Committee, French Agency of Medicinal Products (1992-2013).
In 2010, he founded PathoQuest, a spin-out of Institut Pasteur dedicated to the comprehensive testing of biologicals using untargeted Next Generation Sequencing (NGS).
Serving as its Chief Scientific Officer (CSO) till 2016, he currently acts as a Scientific Advisor for the company.
Contact us
U.S.
466 Devon Park Dr
Wayne, PA 19087
United States
Sign up for our latest news
Follow Us
France
+33 (0)1 70 82 17 90
Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France
Sign up for our latest news
Follow Us
How can PathoQuest help?
